Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
Ligand Binding Sites02:40

Ligand Binding Sites

Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-protein Interfaces02:04

Protein-protein Interfaces

Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a polypeptide...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Predicting the Metabolic Sites by Flavin-Containing Monooxygenase on Drug Molecules Using SVM Classification on Computed Quantum Mechanics and Circular Fingerprints Molecular Descriptors.

PloS one·2017
Same author

Anti-proliferative effect on a colon adenocarcinoma cell line exerted by a membrane disrupting antimicrobial peptide KL15.

Cancer biology & therapy·2015
Same author

Antimicrobial peptide m2163 or m2386 identified from Lactobacillus casei ATCC 334 can trigger apoptosis in the human colorectal cancer cell line SW480.

Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine·2015
Same author

Constructing a linear QSAR for some metabolizable drugs by human or pig flavin-containing monooxygenases using some molecular features selected by a genetic algorithm trained SVM.

Journal of theoretical biology·2014
Same author

Virtual Screening of Some Active Human Macrophage Migration Inhibitory Factor Antagonists.

Journal of biomolecular screening·2014
Same author

Interaction between trehalose and MTHase from Sulfolobus solfataricus studied by theoretical computation and site-directed mutagenesis.

PloS one·2013

Related Experiment Video

Updated: Jul 5, 2026

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes
07:59

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes

Published on: March 25, 2014

Predicting the MHC-peptide affinity using some interactive-type molecular descriptors and QSAR models.

Thy-Hou Lin1

  • 1Institute of Molecular Medicine, Department of Life Science, National Tsing Hua University, Hsinchu, Taiwan.

Methods in Molecular Biology (Clifton, N.J.)
|May 3, 2008
PubMed
Summary

This study models peptidomimetic inhibitors binding to the HLA-DR4 receptor using 3D quantitative structure-activity relationship (QSAR) methods. These computational approaches aid in understanding drug interactions and designing new inhibitors.

More Related Videos

Computational Prediction of Amino Acid Preferences of Potentially Multispecific Peptide-Binding Domains Involved in Protein-Protein Interactions
06:50

Computational Prediction of Amino Acid Preferences of Potentially Multispecific Peptide-Binding Domains Involved in Protein-Protein Interactions

Published on: January 26, 2024

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins
05:08

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins

Published on: July 8, 2025

Related Experiment Videos

Last Updated: Jul 5, 2026

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes
07:59

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes

Published on: March 25, 2014

Computational Prediction of Amino Acid Preferences of Potentially Multispecific Peptide-Binding Domains Involved in Protein-Protein Interactions
06:50

Computational Prediction of Amino Acid Preferences of Potentially Multispecific Peptide-Binding Domains Involved in Protein-Protein Interactions

Published on: January 26, 2024

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins
05:08

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins

Published on: July 8, 2025

Area of Science:

  • Computational chemistry
  • Molecular modeling
  • Pharmacology

Background:

  • Understanding ligand-receptor interactions is crucial for drug discovery.
  • Major Histocompatibility Complex (MHC) molecules, like HLA-DR4, present peptides and are targets for therapeutic intervention.
  • Peptidomimetic inhibitors offer a promising avenue for modulating these interactions.

Purpose of the Study:

  • To develop and present computational methods for modeling the interaction between peptidomimetic inhibitors and the HLA-DR4 receptor.
  • To utilize 3D quantitative structure-activity relationship (QSAR) techniques for this modeling.
  • To explore the application of specific software and analytical procedures for QSAR analysis.

Main Methods:

  • Generation of theoretical structures for peptidomimetic inhibitors.
  • Conformation definition via least-square fitting alignment to the HLA-DR4 receptor structure.
  • Application of comparative molecular field analysis (CoMFA) using the Cerius2 program.
  • Utilizing principal components analysis (PCA) for outlier trimming in CoMFA.
  • Direct QSAR analysis with Cerius2 descriptors and genetic function module regression.

Main Results:

  • Successful construction of CoMFA models based on aligned inhibitor structures.
  • Demonstration of PCA's utility in refining QSAR datasets by removing outliers.
  • Presentation of procedures for direct QSAR analysis and regression.

Conclusions:

  • 3D QSAR methods, particularly CoMFA implemented in Cerius2, are effective for modeling peptidomimetic inhibitor interactions with HLA-DR4.
  • Computational modeling provides a framework for understanding structure-activity relationships in this context.
  • The presented methodologies can guide the design of novel peptidomimetic inhibitors targeting HLA-DR4.